Study to Assess the Efficacy and Safety of Orismilast in Psoriasis
Clinical trial NCT05190419 · COMPLETED
Trial details
- NCT number
- NCT05190419
- Sponsor
- UNION therapeutics
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-30
- Primary completion
- 2022-11-24
- Enrollment
- 202
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.